Porteus, Matthew, Md
Clinical trials sponsored by Porteus, Matthew, Md, explained in plain language.
-
New cell therapy aims to rebuild immunity after cancer transplant
Disease control Recruiting nowThis early-phase study is testing whether a new cell therapy called T-allo10 is safe and can help rebuild the immune system after a stem cell transplant for children and young adults with serious blood cancers. The goal is to help the body fight cancer recurrence while trying to …
Phase: PHASE1 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for rare blood disease: gentler transplant trial seeks to replace toxic chemo
Disease control Recruiting nowThis trial is testing a new way to perform stem cell transplants for people with Fanconi anemia, a rare genetic disorder that causes bone marrow failure. The goal is to use a special, processed donor graft and an experimental antibody called JSP-191 during the pre-transplant cond…
Phase: PHASE1, PHASE2 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC